[go: up one dir, main page]

WO2009140670A9 - Methods for assessing colorectal cancer and compositions for use therein - Google Patents

Methods for assessing colorectal cancer and compositions for use therein Download PDF

Info

Publication number
WO2009140670A9
WO2009140670A9 PCT/US2009/044282 US2009044282W WO2009140670A9 WO 2009140670 A9 WO2009140670 A9 WO 2009140670A9 US 2009044282 W US2009044282 W US 2009044282W WO 2009140670 A9 WO2009140670 A9 WO 2009140670A9
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
colorectal cancer
assessing colorectal
assessing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/044282
Other languages
French (fr)
Other versions
WO2009140670A2 (en
Inventor
Mitch Raponi
Greg M. Arndt
Lesley Dossey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Diagnostics LLC
Original Assignee
Veridex LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex LLC filed Critical Veridex LLC
Priority to BRPI0911972A priority Critical patent/BRPI0911972A2/en
Priority to JP2011509787A priority patent/JP2011520454A/en
Priority to CA2725477A priority patent/CA2725477A1/en
Priority to EP09747751A priority patent/EP2283161A4/en
Priority to MX2010012542A priority patent/MX2010012542A/en
Publication of WO2009140670A2 publication Critical patent/WO2009140670A2/en
Publication of WO2009140670A9 publication Critical patent/WO2009140670A9/en
Priority to IL209078A priority patent/IL209078A0/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PCT/US2009/044282 2008-05-16 2009-05-18 Methods for assessing colorectal cancer and compositions for use therein Ceased WO2009140670A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
BRPI0911972A BRPI0911972A2 (en) 2008-05-16 2009-05-18 methods for assessing colorectal cancer and compositions for their use
JP2011509787A JP2011520454A (en) 2008-05-16 2009-05-18 Methods for assessing colorectal cancer and compositions for use in such methods
CA2725477A CA2725477A1 (en) 2008-05-16 2009-05-18 Methods for assessing colorectal cancer and compositions for use therein
EP09747751A EP2283161A4 (en) 2008-05-16 2009-05-18 METHOD FOR EVALUATING COLORECTAL CANCER AND COMPOSITIONS THEREFOR
MX2010012542A MX2010012542A (en) 2008-05-16 2009-05-18 Methods for assessing colorectal cancer and compositions for use therein.
IL209078A IL209078A0 (en) 2008-05-16 2010-11-02 Methods for assessing colorectal cancer and compositions for use therein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5376008P 2008-05-16 2008-05-16
US61/053,760 2008-05-16

Publications (2)

Publication Number Publication Date
WO2009140670A2 WO2009140670A2 (en) 2009-11-19
WO2009140670A9 true WO2009140670A9 (en) 2010-03-18

Family

ID=41319374

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/044282 Ceased WO2009140670A2 (en) 2008-05-16 2009-05-18 Methods for assessing colorectal cancer and compositions for use therein

Country Status (8)

Country Link
EP (1) EP2283161A4 (en)
JP (1) JP2011520454A (en)
KR (1) KR20110015013A (en)
BR (1) BRPI0911972A2 (en)
CA (1) CA2725477A1 (en)
IL (1) IL209078A0 (en)
MX (1) MX2010012542A (en)
WO (1) WO2009140670A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120088687A1 (en) * 2010-10-08 2012-04-12 Baylor Research Institute MicroRNAs (miRNA) as Biomarkers for the Identification of Familial and Non-Familial Colorectal Cancer
EP2942403B1 (en) * 2010-12-01 2017-04-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for predicting the outcome of a cancer by analysing mirna expression
EP2619587A4 (en) * 2011-01-13 2013-11-13 Ind Tech Res Inst BIOMARKERS FOR RECURRENCE PREDICTION OF COLORECTAL CANCER
NO3051026T3 (en) * 2011-10-21 2018-07-28
JP6156621B2 (en) * 2012-02-14 2017-07-05 国立大学法人 岡山大学 Data acquisition method for ATLL diagnosis, ATLL diagnosis kit, and ATLL diagnosis system
WO2013160474A2 (en) * 2012-04-26 2013-10-31 Instituto Aragonés De Ciencias De La Salud miRNAs EXPRESSION IN HEMATOLOGICAL DISEASES
WO2015126886A1 (en) * 2014-02-18 2015-08-27 Baylor Research Institute Mir-320e and colorectal cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2703986A1 (en) * 2007-10-30 2009-05-07 Veridex, Llc Process for monitoring colorectal cancer

Also Published As

Publication number Publication date
IL209078A0 (en) 2011-01-31
MX2010012542A (en) 2010-12-21
KR20110015013A (en) 2011-02-14
CA2725477A1 (en) 2009-11-19
JP2011520454A (en) 2011-07-21
EP2283161A4 (en) 2012-03-28
WO2009140670A2 (en) 2009-11-19
EP2283161A2 (en) 2011-02-16
BRPI0911972A2 (en) 2019-09-24

Similar Documents

Publication Publication Date Title
PL2173379T3 (en) Compositions and methods for treating and diagnosing cancer
PL2155188T3 (en) Methods and compositions for treating recurrent cancer
IL210153A0 (en) Nutrigenomics methods and compositions
ZA201001300B (en) Antigen-asjuvant compositions and methods
ZA201103416B (en) Anti-cxcr1 compositions and methods
GB0819530D0 (en) Methods and compositions
IL207212A0 (en) 4-pyridinone compounds and their use for cancer
GB0721291D0 (en) Methods and compositions
IL205248A0 (en) Compositions and methods for making androstenediones
SI2187967T1 (en) Methods and compositions for treating cancers
WO2009140670A9 (en) Methods for assessing colorectal cancer and compositions for use therein
GB0719526D0 (en) Compositions and methods
WO2009158447A9 (en) Materials and methods for suppressing and/or treating neurofibroma and related tumors
GB0822345D0 (en) Methods and compositions for cancer prognosis
GB0811250D0 (en) Methods and compositions
EP2363499A4 (en) Colorectal cancer diagnostic method
AU2014200650C1 (en) Anti-CXCR1 compositions and methods
AU2008906027A0 (en) Assessment of risk for colorectal cancer
AU2007906337A0 (en) Assessment of risk for colorectal cancer
AU2007901147A0 (en) Assessment of risk for colorectal cancer
AU2008903953A0 (en) Methods and compositions
AU2008904402A0 (en) Methods and compositions
IL210713A0 (en) Compositions and methods for determininig the prognosis of bladder urothelail cancer
HK1169951A (en) Methods and compositions for treating solid tumors and other malignancies
AU2007904579A0 (en) Methods and compositions

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09747751

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2011509787

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2725477

Country of ref document: CA

Ref document number: MX/A/2010/012542

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20107028055

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2009747751

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0911972

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20101116